Session 20

 

Sunday, September 3
4:30 – 6:30 pm

Room 18

 

 

Laryngo-Pharyngeal reflux

 

Chairs: Jonathan Bock (USA) – Joel H. Blumin (USA)

Discussant:  Peter Dettmar (UK)

 

• Should pepsin detection be considered a first line diagnostic test for airway reflux? Peter Dettmar (UK)
• What are the effects of pepsin on normal laryngeal epithelial cells? Sang-Hyuk Lee (Korea)
• What is the correlation of dual pH multichannel intraluminal impedance and salivary pepsin in the management of laryngopharyngeal reflux symptoms? Jonathan Bock (USA)
• What is the role of aspiration in the development of ventilator associated complications?
  Rahul Nanchal (USA)
• What is the evidence of reflux in idiopathic subglottic stenosis? Joel H. Blumin (USA)
• What is the status of reflux therapies that target pepsin? Nikki Johnston (USA)
• What is the role of type II diabetes in the prevention and treatment of aero-digestive cancers?
  Frank Ondrey (USA)